DNA Virus Infections  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT01706575 / 2012-000080-25: A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression

Completed
2b
76
Europe
Pegylated Interferon (Peginterferon) Alfa-2a, Pegasys, Nucleos(t)ide Analogues (NA)
Hoffmann-La Roche
Hepatitis B, Chronic
09/13
11/14
NCT01143662: Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Completed
2
205
RoW
Ypeginterferon alfa-2b, Peginterferon alfa-2a, Pegasys
Xiamen Amoytop Biotech Co., Ltd., Peking University First Hospital
Chronic Hepatitis B
04/11
04/12
SOFIA-LTT , NCT00442572: Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

Completed
2
21
Europe
PEGASYS [peginterferon alfa-2a]
Hoffmann-La Roche
Hepatitis B, Chronic
04/12
04/12
LIRA-B, NCT01204762 / 2010-020387-38: Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Completed
2
197
US, Canada, Europe, RoW
pegIFN, pegIFNα-2a, Pegasys, PegIFN lambda, BMS-914143, Entecavir, Baraclude
Bristol-Myers Squibb
Hepatitis B Virus
12/13
12/13
NCT02233075: REP 2139-Ca / Pegasysâ„¢ Combination Therapy in Hepatitis B / Hepatitis D Co-infection

Completed
2
12
RoW
REP 2139-Ca + Pegasys (TM), Pegasys(TM) = pegylated interferon alpha-2a
Replicor Inc.
Chronic HBV Infection (HBeAg Negative)
11/16
05/17
Monarch, NCT02577029 / 2015-005499-46: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

Terminated
2
79
Europe, RoW
ARC-520, entecavir, Baraclude, pegylated interferon alpha 2a, Peginterferon, Pegasys, tenofovir disoproxil, Viread, antihistamine
Arrowhead Pharmaceuticals
Hepatitis B, Hepatitis D
12/16
12/16
NCT03109730: Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B

Completed
1b/2a
38
Europe, RoW
ABI-H0731, Placebo for ABI-H0731, Entecavir, ETV, Tenofovir Disoproxil Fumarate, TDF, Pegasys, peginterferon alfa-2a
Assembly Biosciences
Chronic Hepatitis B
03/18
06/18
NCT00964665: Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects

Terminated
1/2
141
Europe, RoW
albinterferon alfa-2b, Pegasys®
Novartis Pharmaceuticals, Human Genome Sciences Inc.
Chronic Hepatitis B
11/10
 
NCT02646189: Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients

Completed
1/2
12
RoW
REP 2139-Ca, Zadaxin, thymosin alpha 1, Pegasys, pegylated interferon alpha-2a
Replicor Inc.
Hepatitis B, Chronic
08/13
08/13
NCT01997944: Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients

Completed
1/2
32
RoW
Human Serum ALbumin/interferon alpha2a, Pegasys
Beijing Bio-Fortune Ltd.
Chronic Hepatitis B
09/14
11/14

Download Options